3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Hematologic Neoplasms
4
Solid Tumor
1
Primary Myelofibrosis
1
Neoplasms
1
Myeloproliferative Disorders
1
Interventions
fludarabine phosphate
38
Cyclophosphamide
37
Peripheral Blood Stem Cell Transplantation
32
Busulfan
28
Tacrolimus
26
Whole-Body Irradiation
20
Mycophenolic Acid
19
Methotrexate
17
Antilymphocyte Serum
17
ruxolitinib
16
fludarabine
14
Filgrastim
13
Cyclosporine
12
Melphalan
11
Radiotherapy
9
Etoposide
9
thymoglobulin
8
Psychiatric Rehabilitation
8
Prednisone
8
Methylprednisolone
8
Cytarabine
6
Cord Blood Stem Cell Transplantation
6
Thiotepa
5
Sirolimus
5
Imatinib Mesylate
5
Flow Cytometry
5
Azacitidine
5
Alemtuzumab
5
sargramostim
4
merphos
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Primary Myelofibrosis
×
fedratinib
×
Clear all
NCT03952039
2025-08-28
FREEDOM2
Celgene
Phase 3
Completed
202 enrolled
23 charts